Perbedaan Equity Development Investment Tbk. dan Indofarma Tbk.: Equity Development Investment Tbk. diperdagangkan di Rp106 (kapitalisasi pasar 1,92 T, volume 24 jam 294,19 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Equity Development Investment Tbk. jauh lebih besar — sekitar 4,9× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GSMF | INAF | |
|---|---|---|
Kapitalisasi Pasar | 1,92 T | 390,51 M |
Volume | 294,19 jt | — |
Lot | 2,94 jt | — |
Perputaran | 36,95 M | — |
Harga Rata-rata | 125,58 | — |
Nilai Transaksi | 36,95 M | — |
Harga Ekuilibrium Indikatif | 106 | — |
Volume Ekuilibrium Indikatif | 8,47 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Selengkapnya di halaman GSMF →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →